Cluster 223: metastatic cancer breast patients prior chemotherapy evidence disease received eligible 
Cluster 702: inflammatory breast cancer tumors including women disease pagets evidenced assessment 
Cluster 1169: neoadjuvant chemotherapy therapy planned received surgery cancer prior breast patients 
Cluster 2165: docetaxel prior treatment chemotherapy cabazitaxel prostate sensitive cancer received metastatic 
Cluster 2360: advanced cancer metastatic breast diagnosis therapy disease prior received solid